The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.

Conclusions: In the treatment of AHF with reduced EF after hospitalization, mortality benefits of carvedilol and bisoprolol were comparable.
PMID: 30317846 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - October 16, 2018 Category: Internal Medicine Authors: Choi KH, Lee GY, Choi JO, Jeon ES, Lee HY, Lee SE, Kim JJ, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Kim KH, Cho MC, Park HY, Oh BH Tags: Korean J Intern Med Source Type: research